Does CLOBAZAM Cause Hyperammonaemic encephalopathy? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Hyperammonaemic encephalopathy have been filed in association with CLOBAZAM (Clobazam). This represents 0.2% of all adverse event reports for CLOBAZAM.
25
Reports of Hyperammonaemic encephalopathy with CLOBAZAM
0.2%
of all CLOBAZAM reports
1
Deaths
10
Hospitalizations
How Dangerous Is Hyperammonaemic encephalopathy From CLOBAZAM?
Of the 25 reports, 1 (4.0%) resulted in death, 10 (40.0%) required hospitalization, and 5 (20.0%) were considered life-threatening.
Is Hyperammonaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOBAZAM. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does CLOBAZAM Cause?
Drug ineffective (1,918)
Seizure (1,787)
Off label use (957)
Somnolence (890)
Foetal exposure during pregnancy (531)
Multiple-drug resistance (486)
Epilepsy (464)
Drug interaction (431)
Fatigue (418)
Status epilepticus (366)
What Other Drugs Cause Hyperammonaemic encephalopathy?
VALPROIC ACID (455)
FLUOROURACIL (156)
VALPROATE (120)
DIVALPROEX (119)
OXALIPLATIN (107)
TOPIRAMATE (101)
RISPERIDONE (96)
QUETIAPINE (91)
LEVETIRACETAM (71)
LEUCOVORIN (62)
Which CLOBAZAM Alternatives Have Lower Hyperammonaemic encephalopathy Risk?
CLOBAZAM vs CLOBETASOL
CLOBAZAM vs CLOBETASONE
CLOBAZAM vs CLODRONATE
CLOBAZAM vs CLOFARABINE
CLOBAZAM vs CLOFAZIMINE